Ursal, Kent B.

HRN: 22-41-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2023
CEFUROXIME 750MG (VIAL)
08/23/2023
08/30/2023
IV
216mg
TID
PCAP-C; AGE W/ Mod. Dehydration
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: